Overview
The MSc in Industrial Pharmaceutical Sciences, Operations and Management may be taken full-time over 12 months or part-time over 24 months from the date of first registration for the programme.
Full-time Students:
Full-time students will complete 90 credits over a 12-month period. Full-time students take taught modules to the value of 60 credits across semester 1 and semester 2, with 40 credits being delivered in semester 1 and 20 credits delivered in semester 2. In semester 1, teaching will be delivered predominantly on campus through lectures, workshops, and practical sessions. In semester 2, teaching will be delivered through a blended approach of remote lectures, online (live) workshops, and some in-person workshops.
Students will have an option in semester 2 to select 10 elective credits in operations, or digital transformation and novel products. In semesters 2 and 3, students will undertake an 8-month industrial placement. While on placement, students will complete a 30-credit industry-based project and placement. A work placement rubric will guide the completion and assessment of the project and work-based learning participation.
Part-time Students:
Part-time students will complete 90 credits over a 24-month period. Part-time students will complete 30 credits in each academic year, with 15 credits in each semester. Part-time students will be industry based and not complete an industrial placement. Part-time students will attend lectures remotely, in person on campus as well as in the workplace. Teaching will be delivered predominantly on campus through lectures, workshops, and practical sessions across all semesters. A rubric will guide the completion and assessment of the project participation.
Notes:
- Taught modules will be offered on a cyclical basis over alternative years for part-time students.
- Depending on numbers, not all electives may run in a given year.
Exit Award: Postgraduate Diploma in Industrial Pharmaceutical Sciences, Operations and Management (NFQ Level 9, Major Award)
Upon successful completion of Part I modules to the value of 60 credits, students may opt to exit the programme and be conferred with a Postgraduate Diploma in Industrial Pharmaceutical Sciences, Operations and Management. Students taking an exit award cannot subsequently register for the remainder of the Masters.
Programme Requirements
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.
Programme Requirements
Full-time
Module List
| Code |
Title |
Credits |
| |
| PF6026 | Pharmaceutical Technology and Unit Operations with Regulatory Insights | 5 |
| PF6027 | Pharmaceutical GxP and Regulatory Science | 5 |
| PF6032 | Bioprocessing Unit Operations | 5 |
| PF6033 | Pharmaceutical Analysis and Analytics | 5 |
| PF6045 | Pharmaceutical Operations & Management | 10 |
| BU6514 | Business Case for Analytics | 5 |
| MG6024 | Developing Management and Leadership Skills for Organisational Effectiveness | 10 |
| MG6025 | Project Management | 5 |
| 10 |
| PF6029 | Biotechnology-derived and Advanced Therapy Medicinal Products (ATMPs) | 5 |
| PF6044 | Digital Transformation in the (Bio)pharma Industry | 5 |
| PF6035 | Lean Six Sigma for BioPharma | 10 |
| PF6042 | Contract and External Manufacturing in Pharma and Biopharma | 10 |
| |
| PF6036 | Industrial-based Dissertation and Placement | 30 |
| Total Credits | 120 |
Part-time
Module List
| Code |
Title |
Credits |
| |
| |
| |
| MG6025 | Project Management | 5 |
| PF6026 | Pharmaceutical Technology and Unit Operations with Regulatory Insights | 5 |
| PF6027 | Pharmaceutical GxP and Regulatory Science | 5 |
| PF6028 | Process Control and Validation for Pharmaceutical Processes | 5 |
| PF6032 | Bioprocessing Unit Operations | 5 |
| PF6033 | Pharmaceutical Analysis and Analytics | 5 |
| |
| |
| BU6514 | Business Case for Analytics | 5 |
| MG6024 | Developing Management and Leadership Skills for Organisational Effectiveness | 10 |
| PF6034 | Pharmaceutical Operations | 5 |
| 10 |
| PF6029 | Biotechnology-derived and Advanced Therapy Medicinal Products (ATMPs) | 5 |
| PF6044 | Digital Transformation in the (Bio)pharma Industry | 5 |
| PF6035 | Lean Six Sigma for BioPharma | 10 |
| PF6042 | Contract and External Manufacturing in Pharma and Biopharma | 10 |
| |
| PF6039 | Industry-based Dissertation | 30 |
| Total Credits | 120 |
Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards Book and for each module in the Book of Modules.
Programme Learning Outcomes
Programme Learning Outcomes for MSc (Industrial Pharmaceutical Sciences, Operations and Management) (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:
1
1-1
Design, differentiate, and execute biopharmaceutical unit processes and analytical methods in a good manufacturing practice (GMP) environment.
1-2
2
Critique the theoretical aspects of quality systems, regulatory processes, and validation approaches and differentiate how they are applied to biopharmaceutical industry in a real-world environment.
1-3
3
Appraise, assess and problem solve common manufacturing issues encountered in the biopharmaceutical industry using scientific problem solving and data analysis.
1-4
4
Apply Lean Six Sigma, supply chain, and project management principles within an operations environment in the pharmaceutical sciences sector and beyond.
1-5
5
Communicate effectively within the workplace through written and verbal formats including scientific and technical writing.
1-6
6
Collaborate, lead, and manage effectively within the workplace through the application of leadership, organisational dynamics, and management theory.
1-7
7
Evaluate, identify, and describe trends in digital transformation, industry 4.0 as applied to the biopharma industry (Pharma 4.0).
1-8
8
Compare and contrast data and data analytics and appraise how data analytics can beused to manage and improve manufacturing processes in the biopharma industry.
